Product Program year 2019 Source: CMS Open Payments

4

Drug Respiratory

General payments

$5,350

6 payments

Research payments

0 payments

Through program year 2019, $5,350 in general payments and $0 in research payments were reported against 4 (Respiratory).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row

Year	Kind	Amount	Payments
2019	General	$5,350	6

Breakdown

Who paid General payments · program year 2019

Cipla USA Inc. $5,350 6 payments

Top recipients General payments · program year 2019

Gregory Tino Critical Care Medicine · Philadelphia, PA $2,200 41% · 2 payments
Mark Jennings Pulmonary Disease · Baltimore, MD $950 18% · 1 payment
Elliott Dasenbrook Pulmonary Disease · Cleveland, OH $850 16% · 1 payment
John Lipuma Pediatric Infectious Diseases · Ann Arbor, MI $750 14% · 1 payment
Patrick Flume Pulmonary Disease · Charleston, SC $600 11% · 1 payment

Each share is of general payments naming this product in 2019.

Specialties paid General payments · program year 2019

Pulmonary Disease Internal Medicine $2,400 45% · 3 practitioners
Critical Care Medicine Internal Medicine $2,200 41% · 1 practitioner
Pediatric Infectious Diseases Pediatrics $750 14% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019

Pennsylvania $2,200 41% · 1 recipient
Maryland $950 18% · 1 recipient
Ohio $850 16% · 1 recipient
Michigan $750 14% · 1 recipient
North Carolina $600 11% · 1 recipient

Each share is of general payments naming this product in 2019 where a state was reported.

Records

6 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.